Kissei Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Kissei Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Kissei Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Kissei Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Kissei Pharmaceutical Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11759464B2 | Grant | Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss | A61K31/519; A61K31/565; A61K31/57; A61P15/00; A61P5/00 | September 19, 2023 |
| US20230286998A1 | Application | Succinate salts of octahydrothienoquinoline compound and crystals thereof | A61K31/4365; A61P25/00; A61P25/16; A61P5/10; C07B2200/13; C07C55/10; C07D495/04 | September 14, 2023 |
| JP2023113715A | Application | Gonadotropin-releasing hormone antagonist dosage regimen for treatment of endometriosis | A61K2300/00; A61K31/519; A61K31/565; A61K31/57; A61K38/09; A61K45/06; A61P15/00; A61P15/02; G01N33/74 | August 16, 2023 |
| WO2023149546A1 | Application | Oral solid preparation | A61K31/519; A61K47/26; A61K47/38; A61K9/20; A61K9/28; A61P5/24 | August 10, 2023 |
| CN116270656A | Application | Usage and dosage of endometriosis therapeutic agent | A61K31/519; A61P15/00; A61P15/02; A61P29/00 | June 23, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer